{[(2,4-dichlorophenyl)methyl]sulfonyl}benzene | 90691-46-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: {[(2,4-dichlorophenyl)methyl]sulfonyl}benzene
• 英文别名: 2,4-dichlorobenzyl phenyl sulfone；(2,4-Dichlor-benzyl)-phenyl-sulfon；1-(benzenesulfonylmethyl)-2,4-dichlorobenzene
• CAS: 90691-46-6
• 化学式: C₁₃H₁₀Cl₂O₂S
• 分子量: 301.193
• InChiKey: YWZAZLCVWGYEDC-UHFFFAOYSA-N

物化性质

• 熔点：
  128-128.5 °C
• 沸点：
  472.8±45.0 °C(Predicted)
• 密度：
  1.395±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  18
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.08
• 拓扑面积：
  42.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  {[(2,4-dichlorophenyl)methyl]sulfonyl}benzene 、 methyl 3-O-benzyl-2,4,6-trideoxy-6-iodo-α-D-erythro-hexopyranoside 以 N,N-二甲基甲酰胺 为溶剂， 反应 2.5h， 生成
  参考文献：
  名称：

  甲基3-0-苄基-2,4,6-三苯氧基-6-碘-α-d-己吡喃糖苷，用于合成HMG-CoA还原酶抑制剂的手性合成子

  摘要：

  由D-葡萄糖制备甲基3-0-苄基-2,4,6-三苯氧基-6-碘-α-D-己吡喃糖苷，并证明其具有潜在的手性合成子，可用于制备HMG-CoA还原酶抑制剂。

  DOI：

  10.1016/s0040-4039(00)86809-4
• 作为产物：
  描述：

  2,4-二氯氯苄 在 乙醇 、 双氧水 、 溶剂黄146 作用下， 生成 {[(2,4-dichlorophenyl)methyl]sulfonyl}benzene
  参考文献：
  名称：

  Jumar; Schulze, Journal fur praktische Chemie (Leipzig 1954), 1957, vol. <4> 5, p. 83,87

  摘要：

  DOI：

文献信息

• [EN] PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3<br/>[FR] INHIBITEURS DE LA GLYCOGENE SYNTHASE KINASE 3 A BASE DE PYRROLE
  申请人：CHIRON CORP

  公开号：WO2004018455A1

  公开（公告）日：2004-03-04

  New pyrrole based compounds, compositions and methods of inhibiting the activity of glycogen synthase kinase (GSK3) in vitro and of treatment of GSK3 mediated disorders in vivo are provided. The methods, compounds and compositions of the invention may be employed alone, or in combination with other pharmacologically active agents in the treatment of disorders mediated by GSK3 activity, such as diabetes, Alzheimer's disease and other neurodegenerative disorders, obesity, atherosclerotic cardiovascular disease, essential hypertension, polycystic ovary syndrome, syndrome X, ischemia, traumatic brain injury, bipolar disorder, immunodeficiency or cancer.

  提供了基于新吡咯烷基化合物的方法、组合物以及抑制体外糖原合成酶激酶（GSK3）活性和治疗体内GSK3介导的疾病的方法。该发明的方法、化合物和组合物可单独使用，也可与其他药理活性剂结合在一起，用于治疗由GSK3活性介导的疾病，如糖尿病、阿尔茨海默病和其他神经退行性疾病、肥胖、动脉粥样硬化心血管疾病、原发性高血压、多囊卵巢综合征、X综合征、缺血、创伤性脑损伤、躁狂抑郁症、免疫功能缺陷或癌症。
• Process for preparing inhibitors of 3-hydroxy-3-methylglutaryl coenzyme
  申请人：Merck & Co., Inc.

  公开号：US04440927A1

  公开（公告）日：1984-04-03

  Totally synthetic analogs of the known inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase, compactin and mevinolin, are prepared from a chiral synthon derived from D-glucose which has the same chirality as the natural products.

  完全合成的3-羟基-3-甲基戊二酰辅酶A还原酶抑制剂compactin和mevinolin的类似物，是由从D-葡萄糖衍生的手性合成物制备而成，其手性与天然产物相同。
• Pyrrole based inhibitors of glycogen synthase kinase 3
  申请人：——

  公开号：US20040077707A1

  公开（公告）日：2004-04-22

  New pyrrole based compounds, compositions and methods of inhibiting the activity of glycogen synthase kinase (GSK3) in vitro and of treatment of GSK3 mediated disorders in vivo are provided. The methods, compounds and compositions of the invention may be employed alone, or in combination with other pharmacologically active agents in the treatment of disorders mediated by GSK3 activity, such as diabetes, Alzheimer's disease and other neurodegenerative disorders, obesity, atherosclerotic cardiovascular disease, essential hypertension, polycystic ovary syndrome, syndrome X, ischemia, traumatic brain injury, bipolar disorder, immunodeficiency or cancer.

  本发明提供了基于新的吡咯类化合物、组合物和方法，用于体外抑制糖原合酶激酶（GSK3）的活性以及治疗GSK3介导的疾病。本发明的方法、化合物和组合物可单独使用或与其他药理活性剂联合使用，用于治疗由GSK3活性介导的疾病，如糖尿病、阿尔茨海默病和其他神经退行性疾病、肥胖症、动脉粥样硬化性心血管疾病、原发性高血压、多囊卵巢综合征、综合征X、缺血、创伤性脑损伤、双相障碍、免疫缺陷或癌症。
• 3-O-benzyl-2,4,6-tridooxy-6-iodo-alpha-D-erythro-hexopyranide useful for
  申请人：Merck & Co., Inc.

  公开号：US04683314A1

  公开（公告）日：1987-07-28

  Totally synthetic analogs of the known inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase, compactin and mevinolin, are prepared from a chiral synthon derived from D-glucose which has the same chirality as the natural products.

  完全合成的3-羟基-3-甲基戊二酰辅酶A还原酶抑制剂，compactin和mevinolin的类似物，是由源自D-葡萄糖的手性合成子制备而成，其手性与天然产物相同。
• PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3
  申请人：Desai C. Manoj

  公开号：US20070244109A1

  公开（公告）日：2007-10-18

  New pyrrole based compounds, compositions and methods of inhibiting the activity of glycogen synthase kinase (GSK3) in vitro and of treatment of GSK3 mediated disorders in vivo are provided. The methods, compounds and compositions of the invention may be employed alone, or in combination with other pharmacologically active agents in the treatment of disorders mediated by GSK3 activity, such as diabetes, Alzheimer's disease and other neurodegenerative disorders, obesity, atherosclerotic cardiovascular disease, essential hypertension, polycystic ovary syndrome, syndrome X, ischemia, traumatic brain injury, bipolar disorder, immunodeficiency or cancer.

  提供了基于新的吡咯基化合物、组合物和方法，用于体外抑制糖原合成酶激酶(GSK3)的活性和治疗GSK3介导的疾病。该发明的方法、化合物和组合物可单独应用，或与其他药理活性剂联合治疗GSK3活性介导的疾病，如糖尿病、阿尔茨海默病和其他神经退行性疾病、肥胖症、动脉粥样硬化性心血管疾病、原发性高血压、多囊卵巢综合征、X综合征、缺血、创伤性脑损伤、双相情感障碍、免疫缺陷或癌症。